Published in J Am Soc Nephrol on March 01, 1997
Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol (2007) 2.41
The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol (2005) 1.97
Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest (2015) 1.43
IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol (2010) 1.24
Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol (2004) 1.11
How anti-neutrophil cytoplasmic autoantibodies activate neutrophils. Clin Exp Immunol (2012) 1.07
Neutrophil serine proteases promote IL-1β generation and injury in necrotizing crescentic glomerulonephritis. J Am Soc Nephrol (2012) 1.06
Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens (2011) 1.06
Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol (2002) 1.05
Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin Exp Immunol (2000) 1.04
Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol (2007) 1.01
The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation. Clin Exp Immunol (1999) 1.00
Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization. Int J Biochem Cell Biol (2008) 0.96
No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis. Clin Exp Immunol (1999) 0.91
A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions. Clin Exp Immunol (1999) 0.90
Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis. J Am Soc Nephrol (2011) 0.90
Neutrophil FcgammaRIIIb allelic polymorphism in anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis. Clin Exp Immunol (2000) 0.89
M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN. Clin J Am Soc Nephrol (2014) 0.88
Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology. J Clin Immunol (2003) 0.86
Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis? Clin Exp Immunol (2000) 0.86
B cell-mediated pathogenesis of ANCA-mediated vasculitis. Semin Immunopathol (2014) 0.85
The immunopathology of ANCA-associated vasculitis. Semin Immunopathol (2014) 0.83
Overview of the Pathogenesis of ANCA-Associated Vasculitis. Kidney Dis (Basel) (2015) 0.82
Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients. Infect Immun (2006) 0.81
Wegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunity. Clin Immunol (2009) 0.81
Involvement of Fcgamma receptors and beta2 integrins in neutrophil activation by anti-proteinase-3 or anti-myeloperoxidase antibodies. Clin Exp Immunol (2003) 0.80
Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls. Ann Rheum Dis (2007) 0.78
IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis. Clin Exp Immunol (2016) 0.77
Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Res Ther (2013) 0.77
Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis. Biomed Res Int (2015) 0.76
Theodore E. Woodward Award. Do ANCA cause small vessel vasculitis? Trans Am Clin Climatol Assoc (2001) 0.75
Pathogenesis of ANCA-associated vasculitis. Rheum Dis Clin North Am (2010) 0.75
Characterization of the CD177 interaction with the ANCA antigen proteinase 3. Sci Rep (2017) 0.75
A Novel Murine Anti-Lactoferrin Monoclonal Antibody Activates Human Polymorphonuclear Leukocytes through Membrane-Bound Lactoferrin and TLR4. Biomed Res Int (2015) 0.75
Re-Examining Neutrophil Participation in GN. J Am Soc Nephrol (2017) 0.75
Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med (1988) 8.01
Small-vessel vasculitis. N Engl J Med (1997) 7.20
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A (1990) 7.19
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell (1995) 4.47
Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A (1995) 3.46
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31
Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature (1995) 3.23
Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network. Ann Intern Med (1992) 2.66
Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med (1990) 2.49
Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol (1989) 2.40
Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest (1983) 2.39
Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int (1992) 2.30
Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol (1991) 2.14
Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol (1996) 2.08
Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int (2006) 2.06
Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol (1996) 1.95
Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis (1990) 1.95
Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int (1994) 1.91
The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol (1995) 1.91
ANCA small-vessel vasculitis. J Am Soc Nephrol (1997) 1.89
A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis (1995) 1.85
Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest (2000) 1.84
Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med (1992) 1.82
Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney Int (2007) 1.77
Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood (1990) 1.71
C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis (1985) 1.64
Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int (2000) 1.64
Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int (2007) 1.64
ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. Kidney Int (2000) 1.53
Efficacy of treatment for unexplained infertility. Fertil Steril (1998) 1.48
Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int (2001) 1.43
Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol (2001) 1.36
Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int (1998) 1.34
Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am J Pathol (1996) 1.33
Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. Am J Pathol (1987) 1.33
Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int (1992) 1.32
Monoclonal antibodies to human renal basement membranes: heterogenic and ontogenic changes. Kidney Int (1983) 1.31
The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol (1999) 1.30
Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol Dial Transplant (1998) 1.28
Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol (1989) 1.28
Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. N Engl J Med (1985) 1.26
Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol (2001) 1.26
Infections associated with subclavian Uldall catheters. Arch Intern Med (1983) 1.21
Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension (1997) 1.21
Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int (1983) 1.20
Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes. J Leukoc Biol (1992) 1.19
Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol (1992) 1.17
Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis. Am J Pathol (2000) 1.13
A genetically determined murine model of infantile polycystic kidney disease. J Urol (1985) 1.12
Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis (1990) 1.11
Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol (1985) 1.09
Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials. Am J Kidney Dis (2000) 1.08
IgA nephropathy associated with seronegative spondylarthropathies. Arthritis Rheum (1982) 1.06
Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues. J Invest Dermatol (1986) 1.05
Interstrain variations in nephritogenicity of heterologous protein in mice. Lab Invest (1982) 1.04
Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin Exp Immunol (2000) 1.04
Diagnostic predictive value of ANCA serology. Kidney Int (1998) 1.04
Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis (1998) 1.03
Exclusively vascular systemic amyloidosis with visceral ischemia. Arch Pathol Lab Med (1982) 1.03
Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase. Clin Exp Immunol (1994) 1.03
Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis (2000) 1.02
Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense. Infect Immun (1986) 1.02
The pathogenic role of antineutrophil cytoplasmic autoantibodies. Am J Kidney Dis (1991) 1.02
The pathology of vasculitis involving the kidney. Am J Kidney Dis (1994) 1.01
Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: diagnostic value and pathogenic implications. The Glomerular Disease Collaborative Network. Am J Kidney Dis (1991) 1.01
Ultrastructural localization of the membrane attack complex of complement in human renal tissues. Am J Kidney Dis (1987) 1.01
Mooren ulcer in South India: serology and clinical risk factors. Am J Ophthalmol (1999) 1.01
Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci U S A (1985) 0.97
ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin Nephrol (2000) 0.97
Immune complex induced glomerular lesions in C5 sufficient and deficient mice. Kidney Int (1986) 0.96